Rose Geoffrey Beran's Form 4 filing
Pulmonx Corp (LUNG) · filed Sep 3, 2026
- Accession no.
- 0001804146-26-000004
- Filed
- Sep 3, 2026, 6:17 PM ET
- Trade date
- Sep 1, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 0 derivative transactions. Open-market sales total $17.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Rose Geoffrey BeranCIK 0001804146 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | SSaleDisposed | −2,213 | $2.26 | −$5,001.38 | 455,498 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −2,390 | $2.26 | −$5,401.4 | 453,108 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −1,530 | $2.26 | −$3,457.8 | 451,578 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −1,746 | $2.26 | −$3,945.96 | 449,832 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.